Secure CheckoutPersonal information is secured with SSL technology.
Free ShippingFree global shipping
No minimum order.
1. Epigenetic Landscapes of the Adversity-exposed Brain
Tania L. Roth
2. Chromosomal Conformations and Epigenomic Regulation in Schizophrenia
3. Progress in Epigenetics of Depression
Eric J. Nestler
4. Epigenetics of circadian rhythms in imprinted neurodevelopmental disorders
Janine M. LaSalle
5. DNA methylation mediating substance abuse; mechanisms and therapeutic opportunities
6. DNA Methylation in Animals Model of Psychosis
Alessandro Guidotti and Dennis R. Grayson
7. Epigenetics of early life stress
8. Epigenetic Drugs for Mood Disorders
9. Behind Epigenetic Alterations in Psychiatric Diseases
Hamid M. Abdolmaleky
10. DNA methylation and its possible role in psychiatric disorders
11. Neuroepigenetics of suicide brain
12. Epigenetic Mechanisms of Traumatic Brain Injuries
13. Non-protein-coding RNAs in Fetal Alcohol Spectrum Disorders
Rajesh C. Miranda
14. Targeting histone-modifications as a therapeutic approach to treat psychosis
15. The epigenetics of early life adversity: current limitations and possible solutions
Epigenetics and Psychiatric Disease, Volume 157, the latest volume in the Progress in Molecular Biology and Translational Science series, includes recent developments on a variety of topics, including the Epigenetic landscapes of the adversity-exposed brain, Chromosomal conformations and epigenomic regulation in schizophrenia, Progress in the epigenetics of depression, the epigenetics of circadian rhythms in imprinted neurodevelopmental disorders, DNA methylation mediating substance abuse, mechanisms and therapeutic opportunities, DNA methylation in animals model of psychosis, Epigenetics of early life stress, Epigenetic drugs for mood disorders, and more.
- Accessible to students and researchers alike, with content that appeals to a variety of readers
- Written by leading authorities in their respective fields of molecular biology
Students, researchers, microbiologists, molecular biologists
- No. of pages:
- © Academic Press 2018
- 22nd June 2018
- Academic Press
- Hardcover ISBN:
- eBook ISBN:
Praise for the Series:
"Maintains the tradition and set-up of the previous volumes and certainly provides up-to-date data on varied aspects of cytology... a valuable acquisition to any library." --The Nucleus
Dr. Grayson has been interested in mechanisms associated with gene expression for over 20 years. He joined the laboratory of Dr. James E. Darnell, Jr. at the Rockefeller University on 1984 to study cell-type specific transcription factors. This led to the identification of HNF3A as a hepatocyte nuclear factor important for activating the expression of multiple genes in hepatocytes. In 1988, Dr. Grayson joined the Fidia-Georgetown Institute for the Neurosciences and with the support of Dr. Erminio Costa, initiated a program in studying gene expression in neurons. From 1994-1998, he moved to the Allegheny University of the Health Sciences in Pittsburgh and developed a program in molecular psychiatry. He continued his interests in psychiatry and joined the Psychiatric Institute in 1998. This represented a unique opportunity to join his long time collaborators, Drs. Costa and Guidotti to pursue molecular underpinnings of schizophrenia. Dr. Grayson has received NRSA post-doctoral support, R01 and K04 funding from the NIH over the years. He has published over 100 papers in peer-reviewed journals and actively reviews NIH grants and post-doctoral fellowships. In addition, Dr. Grayson has been invited to speak at numerous national and international meetings.
Professor of Molecular Neuroscience, University of Illinois at Chicago, IL, USA
Elsevier.com visitor survey
We are always looking for ways to improve customer experience on Elsevier.com.
We would like to ask you for a moment of your time to fill in a short questionnaire, at the end of your visit.
If you decide to participate, a new browser tab will open so you can complete the survey after you have completed your visit to this website.
Thanks in advance for your time.